Xtrackers DAX UCITS ET (DBXD.ETF)

Close: 209.15 (+1.50), Apr 25, 2025
Weak Positive

Low risk

Automatic technical analysis. Medium term, Apr 25, 2025

Xtrackers DAX UCITS ETF 1C shows strong development within a rising trend channel in the medium long term. Rising trends indicate that the ETF experiences positive development and that buy interest among investors is increasing. The price has reacted back after a break of the rectangle formation. There is resistance around 210, which now opens good sales opportunities. A decisive break of this resistance will neutralize the negative signal. The ETF has support at euro 185 and resistance at euro 220. Negative volume balance weakens the ETF in the short term. The ETF is overall assessed as technically slightly positive for the medium long term.

Recommendation one to six months: Weak Positive (Score: 38)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.70%8.86+0.72%
5 days39.982.28%9.99+4.42%
22 days-44.405.88%17.18-2.81%
66 days-38.7211.50%13.67+5.91%

More analyses of Xtrackers DAX UCITS ETF 1C

chart Xtrackers DAX UCITS ETF 1C (DBXD) Candlesticks 22 Days
Candlesticks
chart Xtrackers DAX UCITS ETF 1C (DBXD) Short term
Short term: Weak Negative
chart Xtrackers DAX UCITS ETF 1C (DBXD) Medium term
Medium term: Weak Positive
chart Xtrackers DAX UCITS ETF 1C (DBXD) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.